JP2023538807A5 - - Google Patents

Info

Publication number
JP2023538807A5
JP2023538807A5 JP2023502703A JP2023502703A JP2023538807A5 JP 2023538807 A5 JP2023538807 A5 JP 2023538807A5 JP 2023502703 A JP2023502703 A JP 2023502703A JP 2023502703 A JP2023502703 A JP 2023502703A JP 2023538807 A5 JP2023538807 A5 JP 2023538807A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
sar
compstatin analog
acceptable salt
peg3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023502703A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023538807A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/069798 external-priority patent/WO2022013374A1/en
Publication of JP2023538807A publication Critical patent/JP2023538807A/ja
Publication of JP2023538807A5 publication Critical patent/JP2023538807A5/ja
Pending legal-status Critical Current

Links

JP2023502703A 2020-07-16 2021-07-15 補体因子c3の阻害剤及びそれらの医学的使用 Pending JP2023538807A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20186297 2020-07-16
EP20186297.6 2020-07-16
PCT/EP2021/069798 WO2022013374A1 (en) 2020-07-16 2021-07-15 Inhibitors of complement factor c3 and their medical uses

Publications (2)

Publication Number Publication Date
JP2023538807A JP2023538807A (ja) 2023-09-12
JP2023538807A5 true JP2023538807A5 (cg-RX-API-DMAC10.html) 2024-07-24

Family

ID=71661768

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023502703A Pending JP2023538807A (ja) 2020-07-16 2021-07-15 補体因子c3の阻害剤及びそれらの医学的使用

Country Status (11)

Country Link
US (1) US20230287051A1 (cg-RX-API-DMAC10.html)
EP (1) EP4182023A1 (cg-RX-API-DMAC10.html)
JP (1) JP2023538807A (cg-RX-API-DMAC10.html)
KR (1) KR20230039718A (cg-RX-API-DMAC10.html)
CN (1) CN116209671A (cg-RX-API-DMAC10.html)
AU (1) AU2021309548A1 (cg-RX-API-DMAC10.html)
CA (1) CA3185730A1 (cg-RX-API-DMAC10.html)
CO (1) CO2023001411A2 (cg-RX-API-DMAC10.html)
IL (1) IL299870A (cg-RX-API-DMAC10.html)
MX (1) MX2023000679A (cg-RX-API-DMAC10.html)
WO (1) WO2022013374A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020017385A2 (pt) 2018-02-27 2020-12-15 Zp Spv 3 K/S Análogos de compstatina, métodos e seus usos médicos
KR20240118914A (ko) 2021-01-20 2024-08-05 바이킹 테라퓨틱스 인코포레이티드 대사 및 간 질환 치료를 위한 조성물 및 방법
CA3231953A1 (en) 2021-09-15 2023-03-23 Brian Lian Compositions and methods for the treatment of metabolic and liver disorders
EP4622992A1 (en) * 2022-11-24 2025-10-01 Amyndas Pharmaceuticals US LLC Compstatin analogs for vector-based therapy
CN118812653A (zh) * 2023-04-18 2024-10-22 成都奥达生物科技有限公司 一种长效坎普他汀化合物
CN119219741A (zh) * 2023-06-29 2024-12-31 刘晓蓉 新型补体抑制剂及其制备、应用和产品
CN122255228A (zh) * 2024-12-20 2026-06-23 重庆派金生物科技有限公司 靶向抑制c3与c5补体的双功能多肽、多肽偶联物及它们的应用
US20260234189A1 (en) 2025-01-24 2026-08-13 Boehringer Ingelheim International Gmbh Novel and stable compstatin analogues

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000505068A (ja) 1996-03-13 2000-04-25 トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルベニア 補体活性化を阻害する新規ペプチド類
CZ295838B6 (cs) 1996-09-09 2005-11-16 Zealand Pharma A/S Způsob výroby peptidů
WO1999013899A1 (en) 1997-09-17 1999-03-25 Trustees Of The University Of Pennsylvania Peptides and peptidomimetics for inhibiting complement activation
US7989589B2 (en) 2002-09-20 2011-08-02 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved activity
CN101325963B (zh) 2005-10-08 2016-01-27 博泰迪亚制药公司 用于眼部病症的补体抑制素和其类似物
ES2390828T3 (es) 2005-11-28 2012-11-16 The Trustees Of The University Of Pennsylvania Análogos potentes de la compstatina
WO2008153963A1 (en) 2007-06-08 2008-12-18 The Trustees Of The University Of Pennsylvania Structure of compstatin-c3 complex and use for rational drug design
CA2813049A1 (en) * 2010-09-23 2012-03-29 The Trustees Of The University Of Pennsylvania Modified compstatin with improved stability and binding properties
EP2751161B1 (en) * 2011-08-31 2018-09-19 Huntsmann Advanced Materials Licensing (Switzerland) GmbH Process for the impregnation of air core reactors, impregnated air core reactor and use of an impregnation system
PL2753636T3 (pl) 2011-09-07 2020-05-18 The Trustees Of The University Of Pennsylvania Analogi kompstatyny o ulepszonych właściwościach farmakokinetycznych
WO2014100407A1 (en) 2012-12-19 2014-06-26 The Regents Of The University Of California Compstatin analogs
US10213476B2 (en) * 2014-03-17 2019-02-26 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved potency and pharmacokinetic properties
BR112020017385A2 (pt) * 2018-02-27 2020-12-15 Zp Spv 3 K/S Análogos de compstatina, métodos e seus usos médicos
ES3049784T3 (en) * 2019-08-27 2025-12-18 Zp Spv 3 K/S Compstatin analogues and their medical uses

Similar Documents

Publication Publication Date Title
JP7819087B2 (ja) インターロイキン-23受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用
ES2391974T3 (es) Procedimientos y composiciones para el tratamiento de trastornos gastrointestinales
CN101687006B (zh) 具有改善特性的重建表面活性剂
TW202515892A (zh) 介白素-23受體之肽抑制劑及其治療發炎性疾病之用途
JP7637965B2 (ja) 5.8~8.5のpIを有する少なくとも1つの基礎インスリンならびにカルボキシレート電荷および疎水性ラジカルを有するコポリアミノ酸を含むpH7の注射溶液
JP2024059696A (ja) 5.8~8.5のpIを有する少なくとも1つの基礎インスリンならびにカルボキシレート電荷および疎水性ラジカルを有するコポリアミノ酸を含むpH7の注射溶液
JP2016501204A5 (cg-RX-API-DMAC10.html)
JP2011184442A (ja) Il−21の誘導体
TW202317604A (zh) 用於治療遺傳性血鐵沉積症之鐵調素模擬物
ZA200106530B (en) Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant.
TW200824705A (en) Reconstituted surfactants having improved properties
CN110229216A (zh) 具有改善的药代动力学性质的坎普他汀类似物
JP2014516037A5 (cg-RX-API-DMAC10.html)
JP2022545916A5 (cg-RX-API-DMAC10.html)
WO2018128828A1 (en) Novel hepcidin mimetics and uses thereof
CN103946233A (zh) 多黏菌素衍生物
RU2593757C2 (ru) Пептиды, выделенные из человеческого лактоферрина, и их применение
TW202140073A (zh) 玻尿酸衍生物、醫藥組合物及玻尿酸衍生物-藥物結合體
JP2022535556A (ja) Glp1/2二重アゴニストの非経口医薬組成物
JP6998878B2 (ja) 環状ポリペプチド、それらを得る方法、及びその治療的使用
CN114599389A (zh) 变体fc结构域及其用途
JP2018531284A6 (ja) 環状ポリペプチド、それらを得る方法、及びその治療的使用
JPWO1995015980A1 (ja) 新規な合成ペプチド、それを含有する肺サーファクタント及び呼吸窮迫症候群治療剤
ES2368565T3 (es) Péptidos y composiciones medicinales que contienen los mismos.
JP2026515377A (ja) 神経系修復のためのタンパク質チロシンホスファターゼ楔ドメインペプチドダイマー